Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Carlos Eduardo Alves Batista"'
Autor:
Camila Rocon de Lima Andretta, Kevin Yun Kim, Érica de Brito Mallmann, Camila Pereira Pinto Toth, Josué Basso, Daniela Vianna Pachito, Stephan Sperling, Felipe Cezar Cabral, Marcos Aurélio Maeyama, Carlos Eduardo Alves Batista, Camila Furtado de Souza, Atila Szczecinski Rodrigues, Eno Dias de Castro Filho, Luana Gonçalves Gehres, Sabrina Dalbosco Gadenz, Lauro Augusto Veloso Costa, Igor da Costa Borysow, Renata Albaladejo Morbeck, Marcia Maria Oblonczyk
Publikováno v:
Telemedicine and e-Health. 28:544-550
Background: The coronavirus disease 2019 (COVID-19) pandemic led to the suspension or postponement of care for non-urgent conditions worldwide. Regula Mais Brasil is an initiative of the Unified Health System (SUS) in Brazil to optimize the managemen
Autor:
Emanuelle Roberta da Silva Aquino, Daniela Laranja Gomes Rodrigues, Carlos Eduardo Alves Batista, Josue Basso, Sabrina Dalbosco Gadenz, Kevin Yun Kim, Daniela Vianna Pachito, Stephan Sperling, Soraya Camargo Ito Suffert, Carlos Eduardo Mantese
Publikováno v:
Revista da Associação Médica Brasileira v.68 n.10 2022
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
Revista da Associação Médica Brasileira
Associação Médica Brasileira (AMB)
instacron:AMB
SUMMARY OBJECTIVE: This study aimed to characterize teleconsultations in neurology executed by Regula+Brasil project in Recife, a capital city in northeastern Brazil. METHODS: A descriptive study carried out by four private hospitals, in a partnershi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f49ab81f83489313f5faf0bec27da13
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022001001376
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022001001376
Autor:
Marcelle Maria Portal, Luciane Missiaggia, Matheus Roriz-Cruz, Carlos Eduardo Alves Batista, Liara Rizzi
Publikováno v:
Brain Research. 1678:27-31
Aim Individuals with amnestic mild cognitive impairment (aMCI) are at a high risk to develop Alzheimer’s disease (AD). We compared CSF levels of biomarkers of amyloidosis (Aβ1–42) and neurodegeneration (p-Tau181) in individuals with aMCI and wit
Autor:
Liara, Rizzi, Marcelle, Maria Portal, Carlos Eduardo Alves, Batista, Luciane, Missiaggia, Matheus, Roriz-Cruz
Publikováno v:
Brain research. 1678
Individuals with amnestic mild cognitive impairment (aMCI) are at a high risk to develop Alzheimer's disease (AD). We compared CSF levels of biomarkers of amyloidosis (AβWe collected CSF of individuals clinically diagnosed with aMCI (33) and SCI (12